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Abstract: 
 
Polycyclic aromatic hydrocarbons (PAHs) are major components of diesel exhaust particles 
found in pollutant respirable particles. There is growing evidence that these fossil fuel 
combustion products exacerbate allergic inflammation. Basophils contribute to allergic 
inflammation through the release of preformed and granule-derived mediators. To determine 
whether allergens and PAHs interact, we incubated human basophils with PAHs and measured 
the release of histamine and IL-4 with and without added antigen. None of the PAHs 
induced mediator release by itself and none affected total cellular histamine levels. However, 
several PAHs enhanced histamine release and IL-4 production in response to crosslinking the 
high-affinity IgE receptor, FcεRI. The enhancement seen with 1,6-BaP-quinone involved an 
increase in tyrosine phosphorylation in several different substrates, including the FcεRI-
associated tyrosine kinase, Lyn, and elevated reactive oxygen species (ROS) levels detected 
by dichlorofluorescein fluorescence and flow cytometry. The PAH-induced enhancement of 
mediator release and ROS production could be inhibited with the antioxidant N-acetylcysteine. 
These data provide further evidence that environmental pollutants can influence allergic 
inflammation through enhanced FcεRI-coupled mediator release from human basophils. 
 
Keywords: Human basophils | Polycyclic aromatic hydrocarbons 
 
Article: 
 
Background 
 
Increased industrialization in developed countries has been paralleled by increases in allergic 
asthma [1], [2], [3]. A number of factors are likely to be important in the increase in mortality 
and morbidity from this debilitating disease. These include an inverse relationship between 
infection and atopy, increased exposure to allergens, a lack of physical exercise in the 
population, and an increase in airborne materials [3]. Many epidemiological studies have 
suggested a link among air quality, the increase of atmospheric pollutants, and the increased 
incidence of asthma [4], [5], [6], [7], [8], [9]. 
 
Diesel exhaust particles (DEPs) are important components of pollutant respirable particulate 
matter (PM) in the range of 2.5–10 μm (PM2.5 and PM10) or less. A major chemical component 
of DEPs are compounds that contain three to five benzene rings and are classified as polycyclic 
aromatic hydrocarbons (PAHs). These molecules are ubiquitous in the environment, 
contaminating air, water, and soil [10]. Diesel exhaust is now one of the major causes of 
particulate air pollution in urban districts where concentrations of DEPs can fluctuate from 2 to 
500 μg/m3 during peak automobile traffic. One of the best characterized environmental PAHs 
associated with DEP and PM is benzo(a)pyrene (BaP). BaP and certain oxidation products 
formed in the presence of ultaviolet light or by P450s and other oxidative enzyme (e.g., 
peroxidases), most notably BaP-quinones, activate signaling pathways in lymphoid cells [11]. 
 
The evidence linking exposure to DEP and enhanced allergic inflammation is strong [7], [8]. 
Specifically, Diaz-Sanchez et al. showed that DEPs can enhance the severity of clinical 
symptoms to allergen by enhancing mast cell degranulation [12]. Similarly, Devouassoux et al. 
demonstrated enhanced IL-4 production in basophils exposed to DEP extracts [13]. However, it 
is not clear what component(s) in the DEP milieu is responsible for the observed effects. 
 
To determine whether BaP or any of its known major metabolites may be involved in activation 
of signaling pathways associated with mediator release from human basophils, we exposed 
human basophils to BaP and several of its P450 and non-P450 breakdown products. Basophils 
were exposed to several of these PAHs and IgE and non-IgE-mediated histamine release and 
cytokine production were examined. We found that BaP and several BaP-quinones (BPQs) could 
enhance IgE-mediated histamine release and cytokine production by altering specific signaling 
pathways. In addition, we found that the release of histamine by 1,6-BPQ could be prevented by 
cotreatment with N-acetylcysteine (NAC). Therefore, our data suggest that BPQs or other related 
oxidative agents present in or on DEP can trigger allergic inflammation through enhanced 
antigen-induced mediator release from human basophils through oxidative-stress-associated 
pathways. 
 
Materials and methods 
 
Reagents and monoclonal antibodies 
 
PAHs were obtained from commercial sources at greater than 95% purity. BaP and the 
antioxidant NAC were obtained from Sigma Chemical Company. The 1,6- (1,6-BPQ), 3,6- (3,6-
BPQ), and 6-12 (6,12-BPQ) diones (quinones) as well as the 7,8-dihydrodiol (BP-diol) and 7,8-
diol, 9,10-epoxide (BPDE) of BaP were obtained from the National Cancer Institute Chemical 
Repository at Midwestern Research Institute (Kansas City, MO). The 7,8-quinone of BaP (7,8-
BPQ) was provided by Dr. Trevor Penning (University of Pennsylvania, Philadelphia, PA). All 
stock PAH solutions in dimethylsulfoxide (DMSO) were stored under nitrogen gas in the dark at 
−20°C. Solutions of PAHs were prepared at 100–1000 times their final concentration used for 
experiments in DMSO (Sigma Tissue Culture anyhydrous grade). PAH stock solutions were 
diluted directly into cell culture medium immediately before use. The purity of PAHs was 
periodically examined by high-performance liquid chromatography. Handling, storage, and 
exposure of cells to PAHs were done under yellow light or no light conditions. The final 
concentration of DMSO in cell culture did not exceed 0.1%, and all PAH effects were compared 
to appropriate DMSO-treated control cultures. Anti-4-hydroxyl-3-nitro-5-iodo-phenylacetyl 
(NIP) IgE obtained from the cell line JW8 (ECACC No. 87080706) and NIP–BSA were obtained 
from Serotec (Raleigh, NC). Anti-phosphotyrosine antibodies (PY-99) and anti-Lyn Abs were 
obtained from Santa Cruz (Santa Cruz, CA). Peroxidase-conjugated anti-mouse Abs were 
obtained from The Jackson Labs (West Grove, PA). 5-(and 6)-Chloromethyl-2′, 7′-
dichlorodihydrofluorescein diacetate (DCF) was obtained from Molecular Probes (Eugene, OR). 
 
Isolation of peripheral blood basophils 
 
Venous blood (100–300 ml) was collected from normal donors who had given informed consent 
as approved by the Human Studies Committee at the University of New Mexico. EDTA (0.01% 
v/v) was added as anticoagulant. None of the donors were atopic by history. Basophils were 
purified by centrifugation over Percoll gradients followed by negative selection using magnetic 
beads as previously described [14], [15]. Basophil purities were ≥80% in all the experiments as 
determined with Wrights–Giemsa stain. 
 
Basophil histamine release and IL-4 production 
 
Basophils (80–95%) were acid stripped to remove surface IgE [16] and suspended in fresh 
Iscove’s medium (Iscove’s modified Dulbecco’s medium containing 5% heat-inactivated FBS, 
nonessential amino acids, and 5 μg/ml gentamicin) containing 10 μg/ml of anti-NIP IgE for 4 h 
at 37°C in a 5% CO2 incubator. PAHs (1 μM final) or DMSO (0.001%) was added at various 
times (2 h to 15 min) during the sensitization. Cells were washed with HBSS= (Hanks’ buffered 
saline solution without Ca2+ or Mg2+) [17], resuspended to 0.5–1.1 × 106 basophils/ml in 
prewarmed HBSS+(HBSS with 1.4 mM CaCl2 and 1 mM MgCl2) with NIP–BSA (50 ng/ml for 
histamine or 10 ng/ml IL-4), and incubated at 37°C for 45 min (histamine) or 4 h (IL-4) at 37°C 
in a 5% CO2 incubator. Equal amounts of DMSO (final concentration of 0.001%) were included 
in the non-PAH-challenged cells as a control. Reactions were stopped by centrifugation at 150g 
at 4°C. Supernatants were stored at −70°C. Histamine and IL-4 were measured as previously 
described [15], [17], [18]. For total cellular histamine levels, basophils were freeze–thawed three 
times and histamine was measured in the cellular lysates [19]. 
 
In some experiments we examined the effect of the NAC on histamine release and IL-4 
production. Cells were IgE sensitized as above with or without the addition of NAC (10 mmol) 
for 1 h at 37°C. This concentration gave maximal inhibition of DEP-induced IL-4 production in 
human basophils [13]. Following activation, histamine was measured in the supernatants. 
Alternatively, reactive oxygen species (ROS) levels were measured by FACS analysis (see 
below). 
 
Protein tyrosine phosphorylation 
 
Basophils (≥93% pure) were acid stripped and sensitized with IgE with or without PAHs as 
above. Following activation, basophils (0.5–3 × 106cells/ml) were lysed by 10-min incubation on 
ice in 50 mM Tris, pH 7.5, 150 mM NaCl, 1% Brij, 1 mM sodium orthovanadate, and 1 μg/ml 
each of antipain, leupeptin, aprotinin, and PMSF (lysis buffer). Insoluble material was removed 
by centrifugation at 10,000g for 5 min. The lysate was mixed 8:1 (v/v) with 8X Laemmli sample 
buffer [2% SDS (w/v), 10% (v/v) glycerol, 60 mM Tris (pH 6.8), and 0.1% bromphenol blue], 
heated at 95°C for 5 min, and applied to a 10% polyacrylamide gel (2.0 × 105 cell equivalents). 
Molecular weight markers (Gibco–BRL) were included in each gel. Following SDS–PAGE, 
proteins were transferred to nitrocellulose using a semi-dry apparatus at 400 mA for 1 h. 
Membranes were blocked for 1 h with Blotto (5% bovine serum albumin and 0.05 M Tween -20 
in PBS) and washed three times with Tris-buffered saline containing 0.05% (v/v) Tween 20, pH 
7.4 (TTBS). Membranes were incubated overnight at 4°C with 1 μg/ml of PY Abs in PBS/BSA. 
Membranes were washed three times with TTBS, incubated with peroxidase-labeled goat anti-
mouse IgG (1:40,000 dilution; The Jackson Laboratories) in PBS/BSA for 1 h at RT, washed six 
times with TTBS, and analyzed using ECL as described previously [15]. Blots were stripped for 
30 min with 100 mM 2-mercaptoethanol, 2% SDS (w/v), and 0.5 M Tris–HCl, pH 6.8, at 50°C 
and reprobed with the indicated Abs (1 μg/ml) [15], [17]. 
 
Immunoprecipitation 
 
Basophils (≥95% pure; 2.0–3.0 × 105 cells/condition) were IgE sensitized (±PAHs) and activated 
as above. Cell pellets were lysed in 400 μl of 50 mM Tris, pH 7.5, 150 mM NaCl, 1% Brij, 1 
mM sodium orthovanadate, and 1 μg/ml each of antipain and leupeptin (lysis buffer) and 
incubated for 10 min on ice. Immune complexes were generated by incubating clarified 
supernatants with anti-Lyn antibodies preadsorbed to protein A–Sepharose beads (Pharmacia, 
Uppsala, Sweden) as described [17]. Precipitates were washed 2X with 1 ml of ice-cold lysis 
buffer (without Brij), followed by the addition of 40 μl of 1X Laemmli buffer and proteins 
separated by SDS–PAGE on a 10% gel (2.0–5.0 × 105 cell equivalents/lane). Western blotting 
was performed with anti-PY Abs followed by anti-kinase Abs as described above [15], [17]. 
 
Measurement of reactive oxygen species 
 
ROS production was measured using DCF, a cell-permeant indicator that becomes fluorescent 
upon oxidation by H2O2. Basophils (≥92% pure) were sensitized, PAH exposed, and activated as 
above. After being washed, cells were resuspended in RPMI 1640 medium [19] containing 5 μM 
DCF and incubated at 37°C for 45 min. Cells were washed twice with basophil medium, and 
suspended in PBS and the mean fluorescence was measured by FACS analysis. The data are 
presented as the mean intensty fluorescence (MIF) in which the negative control (DMSO only, 
see below) was adjusted to approximately the same value (125–150 MIF) for each experiment. 
All experiments were performed in duplicate. 
 
Statistical analysis 
 
Histamine release, cytokine production, and ROS formation by PAH and non-PAH-challenged 
basophils were compared using the unpaired t test with Welch’s correction or the Mann–Whitney 
test (Graphpad Prism). 
 
 
Fig. 1. (A) PAHs enhance IgE-mediated histamine release from human basophils. Percoll-enriched, negatively 
selected human basophils (80% purity) were acid stripped and sensitized for 4 h with anti-NIP–IgE (10 μg/ml). The 
indicated PAHs were present (1 μM) during the last 2 h. An equal amount of DMSO alone was added as a control. 
Cells were washed, activated for 45 min with or without 50 ng/ml NIP–BSA, and centrifuged and 
the supernatant was assayed for histamine by ELISA. Results are representative of three separate experiments, each 
done in duplicate. The error bars show SEM. *Values significantly increased with P values given. (B) PAH 
exposure does not increase total cellular histamine levels. Purified basophils (83%) were acid 
stripped, IgE sensitized, and incubated with the same PAHs as in A. Cells were lysed by repeated freeze–
thawing and histamine was measured in the lysate by ELISA. 
 
Results 
 
PAHs enhance IgE-mediated histamine release 
 
To examine the effects of PAHs on basal and FcεRI-mediated histamine release, acid-stripped 
basophils were sensitized for 4 h with 10 μg/ml IgE-anti-NIP [15], with the addition of PAHs (1 
μM) during the final 2–0.25 h. After being washed, the cells were then washed and activated for 
45 min with NIP–BSA. No histamine release was seen when cells were challenged with PAHs 
alone or with crude DEP extracts (up to 4 h). As seen in Fig. 1A,BaP and its 1,6-BPQ and 3,6-
BPQ metabolites significantly enhanced IgE-mediated secretion of histamine from human 
basophils. 
 
The PAH exposures did not induce cell death as measured by trypan blue exclusion (data not 
shown), nor were total cellular histamine levels affected. Basophils contained 1.42 to 1.62 
μg/histamine per 106 cells, with no significant increases seen with PAH incubation (Fig. 1B). 
 
BPQs enhance IgE-mediated IL-4 production 
 
Increased levels of circulating IL-4 is a hallmark of allergic inflammation. No IL-4 production 
was observed when basophils were challenged with PAHs alone (data not shown). However, the 
PAHs 1,6-BPQ and 3,6-BPQ, but not BaP, significantly enhanced IgE-mediated IL-4 production 
(Fig. 2).These data suggest that some metabolites of BaP and perhaps associated with DEPs and 
other PM found in air pollution may enhance human allergic inflammation via enhanced 
mediator release from basophils. 
 
 
Fig. 2. PAHs enhance IgE-mediated IL-4 production from human basophils. Percoll-enriched, negatively selected 
human basophils (96% purity) were sensitized and activated for 4 h with or without 10 ng/ml NIP–BSA as described 
under Materials and Methods. The results from one experiment are representative of three separate donors. 
The SEM is shown by error bars. *Values significantly increased with P values given. 
 
Increased ROS levels in PAH-exposed, IgE-activated basophils 
 
ROS are generated at sites of inflammation and injury and can function as signaling 
intermediates in regulation of fundamental cellular activities [20], [21], [22]. BPQs are well 
known to induce ROS formation through redox-cycling mechanisms [23], [24]. Previous studies 
have suggested a link between PAH exposure and increased ROS levels in other cell 
types [11], [22]. However, the effect of PAH exposure on ROS formation in human basophils 
has not previously been explored. We chose to focus on the 1,6-BPQ PAH because it was 
consistently the most potent enhancer of mediator release in our experiments. As seen in Fig. 
3, antigen-activated basophils did not have significantly elevated ROS levels. However, when 
basophils were first exposed to 1,6-BPQ before antigen activation there was a significant 
increase in cellular ROS levels. Thus, it appears that the 1,6-BPQ enhancement of mediator 
release from human basophils involves an increase in ROS. 
 
 
Fig. 3. PAH enhances IgE-mediated ROS formation in human basophils. Cells were IgE sensitized and exposed 
to DMSO or 1,6-BPQ. After being washed cells were incubated in buffer containing 50 ng/ml NIP–BSA or 1,6-BPQ 
alone (1 μM). Cellular ROS levels were detected by incubating the cells in DCF and detecting the fluorescence 
by FACS analysis. The results are presented as the mean from three combined experiments (three separate donors). 
*Values significantly increased with P values given. 
 
Pahs alter the tyrosine phosphorylation of specific cellular proteins 
 
IgE-mediated human basophil degranulation is initiated by the sequential activation of two 
protein tyrosine kinases, Lyn and Syk, that in turn support the tyrosine phosphorylation of 
specific cellular proteins [17]. To determine whether the enhanced IgE-mediated functional 
responses we observed were associated with PAH-induced changes in total cellular 
phosphorylation, IgE-sensitized basophils were challenged for different times with NIP–BSA 
with or without preincubation with 1,6-BPQ and then lysed and solubilized proteins were 
separated by SDS–PAGE. Western blots were probed with anti-PY Abs. As shown in Fig. 
4A, FcεRI crosslinking stimulated the tyrosine phosphorylation of a number of proteins, 
including species with molecular masses of 105–110, 84, 74, 56, 53, and 50 kDa. Preincubation 
with 1,6-BPQ did not affect basal tyrosine phosphorylation, but it strongly increased the FcεRI-
mediated tyrosine phosphorylation of several of these proteins. 
 
We have previously shown that the tyrosine kinase Lyn (55–56 kDa) is tyrosine phosphorylated 
and activated upon FcεRI crosslinking in human basophils [17]. Certain PAHs have been shown 
previously to activate Lyn in human B cells [25]. We therefore tested the hypothesis that the Lyn 
is one of the hyperphosphorylated bands in the 1,6-BPQ plus antigen-treated samples in Fig. 4A. 
Cells were activated, with or without 1,6-BPQ preincubation, and lysed, and anti-Lyn (Fig. 4B) 
immunoprecipitates were analyzed by immunoblotting with anti-PY Ab. Lyn showed basal 
phosphorylation; this is increased in response to antigen stimulation alone and is further 
increased by 1,6-BPQ treatment prior to antigen stimulation. Densitometry confirmed a 
significant increase in the amount of relative signal obtained from IgE-activated cells pretreated 
with 1,6-BPQ compared to nontreated cells. 
 
 
Fig. 4. (A) 1,6-BPQ exposure affects the protein tyrosine phosphorylation profile in human basophils. IgE-sensitized 
basophils (>90% pure) were incubated with NIP–BSA (50 ng/ml) for the indicated time with or 
without PAH exposure. Cells were lysed and proteins in the cleared cell lysates analyzed by SDS–PAGE (0.64 × 
106 cell equivalents/lane). Proteins were transferred onto nitrocellulose membranes and probed with anti-
phosphotyrosine (PY) Ab. Immunoreactivity was detected using ECL. As a control, cells were incubated with 1,6-
BPQ for 15 min without other stimulation. Similar results were obtained in two experiments. (B) 1,6-BPQ 
pretreatment enhances IgE-mediated Lyn phosphorylation. Basophils (90% purity) were sensitized and challenged 
as above. Lyn was immunoprecipitated and analyzed by Western blotting with anti-PY Abs (top) and stripped and 
reprobed with anti-Lyn Ab (bottom). Each lane shows Lyn immunoprecipitated from 8.0 × 105 cells. Anti-IgE 
stimulation (1 μg/ml; 5 min) was used as a positive control for Lyn phosphorylation [17]. The results are 
representative of two separate experiments. The molecular mass markers (kDa) are indicated. 
 
 
 
Fig. 5. PAH-induced enhancement of mediator release and ROS production is abrogated by NAC. Percoll-enriched, 
negatively selected human basophils (Expt. 1 = 89%; Expt. 2 = 95%) were acid stripped and sensitized for 4 h with 
anti-NIP–IgE (10 μg/ml). Cells were activated for (A) 30 min (histamine) or (B) 4 h (IL-4) with NIP–BSA (50 or 10 
ng/ml) with or without preincubation with NAC (10 mmol for 1 h), 1,6-BPQ (1 μM for 15 min), or both. 
Supernatants were assayed for histamine or IL-4 by ELISA. Results of two separate experiments, each done in 
duplicate, are shown. *Significance at P < 0.001. (C) IgE-sensitized basophils (85–95%) were exposed to DMSO or 
1,6-BPQ with or without NAC preincubation. After being washed cells were incubated in buffer containing 50 
ng/ml NIP–BSA or 1,6-BPQ alone (1 μM). Cellular ROS levels were detected by incubating the cells in DCF and 
detecting the fluorescence by FACS analysis. The results are presented as the mean from two combined experiments 
(two separate donors). No statistically significant changes in ROS levels are shown. 
 
NAC abrogates 1,6-BPQ-induced responses 
 
Increases in cellular levels of ROS can be inhibited using the antioxidant NAC. Based on the 1,6-
BPQ-induced enhancement of mediator release and increased basophil ROS levels, we tested the 
effects of NAC on histamine release, IL-4 production, and ROS levels. NAC treated or untreated 
basophils were challenged with 1,6-BPQ and/or optimal concentrations of allergen and the 
mediator release and ROS production measured as above. As predicted, preexposure of basophils 
to 1,6-BPQ enhanced both histamine release and IL-4 production (Fig. 5A and B). However, 
when the cells were preincubated with NAC no PAH-induced enhancement was seen. Similar to 
what has been shown in other studies [13], [26], NAC produced no clear effects on antigen-
induced mediator release. Cells preincubated with NAC also inhibited increases in basophil ROS 
levels produced by 1,6-BPQ (Fig. 5C). 
 
Discussion 
 
Previous studies have clearly shown that DEP exposure leads to the enhancement of allergic 
inflammation. The purpose of this study was to examine the potential role of PAHs (a major 
component of DEP) in the regulation of mediator release from human basophils. 
 
DEPs and their PAH components are known to increase IgE production in animals and humans 
both in vivo and in vitro [27], [28], [29], [30], [31], [32]. They are also known to increase 
allergic symptoms in animals. In particular, Kobayashi et al. demonstrated increased sneezing 
frequency, nasal secretion volume, and transnasal airway resistance in DEP-exposed guinea 
pigs [33], [34], [35]. These changes were accompanied by an exaggerated increase in 
permeability of nasal vasculature in DEP-challenged animals [36]. Saigai and colleagues [37] 
studied an “asthma-like” condition that develops in mice after prolonged intratracheal challenge 
with DEPs. These animals demonstrated an increase in airway resistance, increased mucous 
production, marked infiltration of eosinophils in bronchi and bronchioles, and a proliferation of 
goblet cells [37], [38]. In other rodent model studies, DEP challenge produced an induction of 
Th2-like cytokines [39], [40], an increase in inflammatory cells in bronchoalveolar lavage (BAL) 
fluid, enhanced airway constriction [39], and eosinophil infiltration, IgE production, and goblet 
cell hyperplasia [41]. Taken together, animals exposed to DEPs develop disease manifestations 
that mimic asthmatic disease processes in humans. 
 
In human studies, DEPs sprayed into the nostrils of test subjects enhanced in vivo IgE production 
in the upper respiratory tract [28]. Using this same model, Saxon and co-workers recently 
showed that exposure to DEPs can enhance the severity of clinical symptoms to allergen, 
presumably by mast cell degranulation [12]. DEPs also act as adjuvants to coadministered 
antigen in nasal provocation challenges. In these studies, nasal lavages from ragweed-sensitized 
subjects were collected at different times after nasal challenge with ragweed allergen. As 
compared with challenge with ragweed alone, challenge with both DEPs and ragweed induced 
markedly higher ragweed-specific IgE but not total IgE levels or IgE-secreting cell numbers. 
Synergy was also observed between the DEPs and ragweed in altering the profile of epsilon 
mRNAs generated by alternative splicing, producing mRNAs that code for different expressed 
IgE proteins [31]. DEP exposure by this method specifically increased total IgE and ε mRNA in 
nasal lavage fluid [28], [29], [42]. Most recently, DEP extracts have been shown to increase both 
histamine release and IL-4 production from human basophils [13]. While it is clear that the DEPs 
and DEP extracts can influence several aspects of the allergic inflammatory process, it is still not 
clear which components(s) is responsible for these effects. 
 
Here, we show that preincubation of human basophils with certain PAHs, most notably BaP, 1,6-
BPQ, and 3,6-BPQ, enhance histamine release and IL-4 production after short exposure times. 
This response appears to involve an increase in the tyrosine phosphorylation of certain proteins. 
Studies examining DEP exposure of human macrophages showed differential phosphorylation of 
certain kinases in exposed versus nonexposed cells [43]. Specifically, we demonstrate that Lyn, 
previously implicated in basophil IgE-mediated signaling pathways, is hyperphosphorylated in 
antigen-activated cells exposed to 1,6-BPQ. In addition, several other proteins were only tyrosine 
phosphorylated in antigen plus 1,6-BPQ-challenged basophils. Similarly, other studies have 
determined that PAHs can increase total B cell tyrosine phosphorylation in the phosphorylation 
of specific molecules including Lyn, Syk, Fyn, ZAP-70, and phospholipase C in human B and T 
cells [11], [25]. We hypothesize that the increase in protein tyrosine phosphorylation may 
enhance the ability of other downstream effectors to efficiently interact and amplify the 
antigen/receptor signals. 
 
We also observed a significant increase in ROS when basophils were exposed to 1,6-BPQ and 
antigen challenged when compared to nonexposed cells. A link between ROS production and 
enhanced allergic mediator release has been suggested. Specifically, blockade of superoxide 
generation prevents high-affinity immunoglobulin E receptor-mediated release of allergic 
mediators by rat mast cell line and human basophils [44]. Through this mechanism basophils 
could contribute to PAH-associated enhancement of allergic inflammation through traditional 
release of allergic mediators but also through release of ROS. Macrophages exposed to DEP 
chemicals produce and release ROS, leading to cellular activation or apoptosis which can be 
abrogated by antioxidants [45]. The effects of ROS on airway function in asthma have been 
studied with isolated airway cells and tissues and with animal models and patients. These studies 
show that release of ROS within the airways may contribute to the initiation and worsening of 
inflammatory respiratory disease [46]. Increased levels of ROS and ROS by-products have been 
found in asthmatics compared to controls [47], [48], [49]. These studies suggest that oxidative 
stress contributes to the initiation and worsening of inflammatory respiratory disease. 
 
Our studies differ from that of Devouassoux et al. where organic extracts of DEPs, which 
presumably include PAHs, induced basophil IL-4 production but not in an antigen-independent 
fashion [13]. The discrepancies are unexplained but may be due to the complexity of molecules 
found in the DEP extracts used in the basophil studies resulting in PAH concentrations much 
lower than the concentrations used in our studies. Our results are more similar to other studies in 
which synergy of antigen and DEPs on cytokine production was observed in in vivo nasal or 
bronchial antigen challenge models [8], [12], [30], [31] which implicated mast cells as the source 
of DEP-induced cytokine production. 
 
We found that 1,6-BPQ-induced enhancement of histamine release, IL-4 production, and ROS 
formation could be blocked using the antioxidant NAC. DEP-induced expression of IL-4 in 
human basophils could be inhibited by first preincubating with NAC [13]. Similarly, blocking 
ROS formation in rodent mast cells inhibits IgE-mediated degranulation [44], [50]. Our data 
support the hypothesis that ROS generation can influence signaling pathways leading to 
histamine release and cytokine production through IgE crosslinking. While the evidence showing 
intracellular ROS levels can be elevated in response to activating signals, it is not known whether 
human mast cells and basophils are capable of releasing ROS. A recent paper found that murine 
mast cells did not produce ROS but macrophage-derived ROS inhibited mediator release [51]. 
Our laboratory has found that mediator release from lung-derived human mast cells is influenced 
by PAHs through a ROS-dependent mechanisms (C.L. Kepley, unpublished observation). We 
are currently investigating whether human FcεRI-positive cells can release ROS as well. 
 
It is not clear whether the PAH-induced differential basophil protein tyrosine phosphorylation 
profile or Lyn phosphorylation is due to a direct BPQ effect or the increase in cellular ROS 
levels. As mentioned above, certain PAHs directly induce tyrosine kinase activation. However, 
ROS have been implicated in the regulation of diverse cellular functions including defense 
against pathogens, intracellular signaling, transcriptional activation, proliferation, and apoptosis. 
Specifically, generation of ROS, such as H2O2, has previously been shown to activate protein 
tyrosine kinases leading to the stimulation of downstream signaling systems including MAP 
kinase and PLC-γ in several cellular systems [52]. 
 
There is growing evidence that compounds in air pollution may lead to enhancement of allergic 
inflammation, but the mechanisms are not clear [8], [53]. The data presented here support the 
hypothesis that particulate matter may directly enhance allergic inflammation through enhanced 
antigen-induced basophil mediator release after PAH exposure. Mast cells and basophils are 
involved in the initiation and propagation of allergic inflammation, including asthma. We used a 
basophil-specific mAb [14] to demonstrate that basophil numbers are significantly increased in 
the lungs of patents dying from asthma compared to asthmatics dying from nonasthmatic 
causes [54]. Mast cells are ubiquitously distributed in tissue and may be expected to encounter 
DEPs and PAHs. Given their involvement in these diseases it is important to understand how 
environmental pollutants affect their functional responses. Through the observations described 
here, particulate air pollutants may enhance the allergen/IgE-induced physiologic mechanisms 
that induce allergic inflammation. They may also contribute to acute asthmatic attack or 
contribute to the chronic conditions that favor this disease in the lungs of asthmatics. 
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